Diabetes mellitus Posts on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Does dapagliflozin protect kidney function in patients with diabetes?

Posted by on Dec 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the effect of dapagliflozin (Farxiga) on kidney disease in patients with type 2 diabetes. It found patients treated with dapagliflozin were significantly less likely to have a decline in kidney function. Some background In type 2 diabetes (T2D), the body no longer regulates blood sugar well. If blood sugar is not...

Read More

Can thiazolidinediones help lower Parkinson’s disease risk in patients with diabetes?

Posted by on Dec 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study investigated whether thiazolidinediones (TZDs) can help lower the risk of Parkinson’s disease (PD) in patients with type 2 diabetes (T2D). The authors concluded that TZDs were associated with a lower risk of PD in these patients. Some background Although anti-diabetes medications can help lower blood sugar...

Read More

Evaluating risk of low blood sugar in patients with diabetes taking insulin degludec

Posted by on Dec 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of switching to insulin degludec (Tresiba) in patients with diabetes mellitus. This study concluded that patients had better blood glucose control and a lower risk of low blood sugar after switching. Some background Insulin therapy is the typical first-line treatment for patients...

Read More

Looking for patients with diabetes receiving insulin to test mobile app

Posted by on Dec 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is looking for patients with diabetes taking insulin to test a mobile app that helps patients understand how blood glucose levels change. The main outcome that will be measured is the average blood glucose level at the beginning versus the end of the study. This study is recruiting in Boston, MA, the US. The details...

Read More

Searching for patients with type 1 diabetes to test once-daily vs thrice-daily oral insulin

Posted by on Dec 20, 2019 in Diabetes mellitus | 0 comments

In a nutshell This trial is testing the effectiveness of once-daily vs thrice-daily oral insulin in patients with type 1 diabetes (T1D). The main outcome is the amount of injected insulin used, and the second outcome is the amount of time blood glucose levels are within specific ranges. This study is being conducted in Orange County, California,...

Read More

Is the off-label use of type-2 diabetes medications in type 1 diabetes causing increased rates of diabetic ketoacidosis?

Posted by on Dec 9, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined the frequency of sodium-glucose cotransporter 2 (SGLT2) inhibitor use in type 1 diabetes (T1D) and the resulting rates of diabetic ketoacidosis (DKA). The study concluded that while the proportion of SGLT2 use in T1D is small, there is a significant associated risk of DKA. Some background There are two...

Read More

Can SGLT2 inhibitors prevent kidney disease in patients with Type 2 diabetes?

Posted by on Nov 25, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effect of SGLT2 inhibitors on symptoms of kidney disease in patients with Type 2 diabetes (T2D). The authors found that these agents helped lower the chance of developing kidney disease in these patients. Some background In patients with diabetes, high blood glucose levels can lead to other health...

Read More

Evaluating combination therapy versus metformin only for patients with Type 2 diabetes

Posted by on Nov 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated whether adding vildagliptin (Galvus) to metformin (Glucophage) could improve the duration of blood glucose control for patients with newly diagnosed Type 2 Diabetes (T2D). The authors found that this treatment combination improved long-term blood glucose control for these patients. Some background...

Read More